Supernus Pharmaceuticals Inc (SUPN)
EBITDA Margin
-13.51%
Quarterly · Period ending:
SUPN EBITDA Margin
Latest reported-13.51%period ending
Latest reported-13.51%period ending
SUPN Quarterly EBITDA Margin (261.46% → -13.51%)
Quarterly ebitda margin
High-resolution chart · PNG
SUPN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -13.506% | |
| 9.7224% | |
| 12.6066% | |
| -17.2553% | |
| 22.9836% | |
| 11.8719% | |
| 25.9688% | |
| 37.0228% | |
| 23.1291% | |
| 11.4874% | |
| 13.7943% | |
| 20.6304% | |
| 3.3254% | |
| 20.2408% | |
| 34.4132% | |
| 12.9995% | |
| 20.4004% | |
| 24.9348% | |
| 13.0097% | |
| 27.9933% | |
| 30.654% | |
| 18.0384% | |
| 35.7412% | |
| 42.9574% | |
| 44.2448% | |
| 38.4529% | |
| 48.197% | |
| 45.9428% | |
| 47.8323% | |
| 37.1903% | |
| 47.9126% | |
| 38.2141% | |
| 37.6741% | |
| 36.6044% | |
| 40.7237% | |
| 33.2347% | |
| 36.1471% | |
| 30.445% | |
| 27.202% | |
| 35.9972% | |
| 24.46% | |
| 15.9396% | |
| 19.1068% | |
| 13.7485% | |
| 11.5856% | |
| 15.0997% | |
| 17.3761% | |
| -0.9431% | |
| 13.4423% | |
| -155.3684% | |
| -107.8092% | |
| -1,672.7128% | |
| -8,914.2349% | |
| -12,072.1088% | |
| -1,148.8073% | |
| -13,505.4945% | |
| -9,748.3516% | |
| -3,787.5% | |
| 201.2595% | |
| -88,100% | |
| -1,090.2667% | |
| 0% | |
| 221.6042% | |
| 261.4639% |